Synergistic Genetic and Chemical Engineering of Probiotics for Enhanced Intestinal Microbiota Regulation and Ulcerative Colitis Treatment
Authors:
- 1 June 2025
- journal article
- Published by Wiley in Advanced Materials
- Vol. 37 (30) , e2417050
Abstract
Live bacterial therapeutics (LBT) hold significant promise for treating ulcerative colitis (UC) by utilizing engineered microorganisms to restore mucosal barrier function, modulate microbiota imbalances, and enhance immunity. However, challenges such as low bacterial survival under harsh gastrointestinal conditions, difficulties in achieving long‐term colonization, and unclear therapeutic targets limit their effectiveness. To address these issues, a novel approach is proposed that integrates genetic and chemical engineering for intestinal flora regulation in UC treatment. This strategy employs bacterial programmability and gene editing to produce bactericidal agents that dynamically modulate the intestinal microecology and utilize controlled chemical modifications to enhance bacterial resistance. Using Escherichia coli Nissle 1917 (EcN) as a model, a polyelectrolyte composite coating is developed that significantly increased bacterial survival in the gastrointestinal tract—40‐fold in the stomach and 74‐fold in the small intestine. Additionally, EcN::mcmA is engineered to overproduce iron‐carrier microcins (MccM) with a “Trojan horse” mechanism to target and disrupt pathogenic bacteria. In a dextran sulfate sodium (DSS)‐induced mouse UC model, EcN::mcmA@P/O treatment effectively reduced inflammation and improved intestinal flora regulation, presenting a promising and potentially safer long‐term solution for UC.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2021A1515220051, 2022A1515010716)
- Guangdong Provincial Pearl River Talents Program (2019QN01Y314)
- National Natural Science Foundation of China (22372061)
This publication has 50 references indexed in Scilit:
- Surface-functionalized bacteria: Frontier explorations in next-generation live biotherapeuticsBiomaterials, 2024
- Engineered Living Materials for Advanced Diseases TherapyAdvanced Materials, 2023
- Polysaccharides from Platycodon grandiflorus attenuates high-fat diet induced obesity in mice through targeting gut microbiotaBiomedicine & Pharmacotherapy, 2023
- Polymerization‐Mediated Multifunctionalization of Living Cells for Enhanced Cell‐Based TherapyAdvanced Materials, 2021
- On‐Demand Bacterial Reactivation by Restraining within a Triggerable NanocoatingAdvanced Materials, 2020
- Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome FeaturesCell, 2018
- An Enzyme‐Coated Metal–Organic Framework Shell for Synthetically Adaptive Cell SurvivalAngewandte Chemie International Edition, 2017
- Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DSM17648: A Pilot StudyProbiotics and Antimicrobial Proteins, 2014
- Immunoglobulin A Coating Identifies Colitogenic Bacteria in Inflammatory Bowel DiseaseCell, 2014
- Spleen size in patients with inflammatory bowel diseaseDiseases of the Colon & Rectum, 1987